NCT03258593 2026-03-17Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)National Institutes of Health Clinical Center (CC)Phase 1 Completed15 enrolled 21 charts